scispace - formally typeset
C

Charles DeCarli

Researcher at University of California, Davis

Publications -  721
Citations -  77364

Charles DeCarli is an academic researcher from University of California, Davis. The author has contributed to research in topics: Dementia & Hyperintensity. The author has an hindex of 125, co-authored 614 publications receiving 65820 citations. Previous affiliations of Charles DeCarli include University of Southern California & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Associations of Amyloid, White Matter Hyperintensities, and Hippocampal Volume with Cognitive Trajectories in the Oldest‐Old: The 90+ Study

TL;DR: This article found that Amyloid pathology, vascular disease pathology, and hippocampal atrophy are associated with cognitive trajectories in older adults, but no prior evidence on how these pathologies influence cognition in the oldest-old.

atrophy and not to intracerebral calcifications in children with symptomatic HIV disease

TL;DR: The relationship between viral load in plasma and cerebrospinal fluid (CSF) and computed tomography (CT) brain scan abnormalities were studied in 39 children between 0.5 and 13 years of age with symptomatic HIV-1 disease as discussed by the authors.
Journal ArticleDOI

MRI free water as a biomarker for cognitive performance: Validation in the markvcid consortium

TL;DR: In this article , Free Water (FW), a Diffusion Tensor Imaging-based biomarker kit has been demonstrated by the MarkVCID consortium to have excellent instrumental validity, and the authors sought to determine its clinical relevance by investigating association of Free Water with clinically meaningful aspects of vascular contributions to cognitive impairment and dementia.
Journal ArticleDOI

Neuroimaging biomarkers of the Amyloid, Tau, Neurodegeneration and Vascular framework in association with sleep duration changes over time

TL;DR: In this paper , the authors evaluated how self-reported sleep duration and its change over time associate with markers of Alzheimer's disease, including myloid, tau, and vascular neuroimaging markers.